14
Participants
Start Date
March 31, 2011
Primary Completion Date
November 30, 2011
Study Completion Date
December 31, 2011
Active
A 5 mg single dose given intravenously via syringe pump over 1 minute.
Placebo
Same as active
Duke Asthma, Allergy and Airway Center, Durham
National Jewish Health, Denver
Lead Sponsor
Nivalis Therapeutics, Inc.
INDUSTRY